Bio Manufacturing Partnering Forum


September 19
Motif Seattle
Seattle, Washington

The biopharmaceutical industry produces medicines that treat and prevent some of the most prevalent and debilitating diseases that affect human health. These medicines are derived from biological sources using highly complex manufacturing processes.

Innovative technologies, many originating in academic labs, can be applied to improve the safety, quality, cost, efficiency, and speed of biopharmaceutical manufacturing. However, bridging the gap from benchtop proof of concept to scale-up for clinical and commercial manufacturing remains a challenge to implementing innovative processes.

Industry Partners Attending
  • Alder Biopharmaceuticals
  • Biomedical Manufacturing Network
  • Digital World Biology LLC
  • Genentech
  • Juno Therapeutics
  • Merck
  • National Center for Therapeutics Manufacturing
  • Renssalaer Polytechnic Institute
  • Sana Biotechnology
  • Shoreline Community College
  • Universal Cells
  • University of Washington
The Bio Manufacturing Partnering Forum (held in conjunction with AUTM’s 2019 Western Region Meeting) will explore how academia and industry can collaborate to validate and scale innovative manufacturing technologies to improve the production of biological therapeutics. Critical issues such as how to speed innovation, how to develop standards that enable more efficient and rapid manufacturing capabilities, and how to educate and train a world-leading biopharmaceutical manufacturing workforce will be examined.

*Tentative schedule, program subject to change

Thursday, September 19

8:30 - 8:45 a.m.       AUTM Welcome
8:45 – 10 a.m.            Opening Plenary

The Evolving and Emerging Challenges of Biopharmaceutical Technical Operations and Manufacturing: a Perfect Storm

The featured speaker, Dr. Patrick Y. Yang, will address the evolving and emerging challenges of biopharmaceutical technical operations and manufacturing. A super star in the bio manufacturing ecosystem, Dr. Yang will offer a forward thinking session on insights into the new generation of bio manufacturing with actionable insights for tech transfer offices. This is a cant-miss discussion.
10 – 10:30 a.m.          Break
10:30 a.m. – Noon Innovation in Bio-manufacturing: Leveraging Technology Transfer to Advance the Manufacturing of New Therapeutics

Gregory Theyel, PhD, Director, Biomedical Manufacturing Network

Mark Fromhold, Alder Biopharmaceuticals
Eric Huang, Genentech
Eric Klavins, University of Washington

Bio-manufacturers are uniquely aware of the challenges faced during the development and manufacturing of biologics, and they have the responsibility to make better, faster, cheaper, and higher quality therapeutics for serving patients. Academia plays a key role in conducting fundamental research and pioneering new technologies; suppliers develop and commercialize new technologies; and regulators ensure that new advancements conform to existing guidelines or develop new guidelines in collaboration with industry. This session will probe how to leverage technology transfer between bio-manufacturers, academia, suppliers, and regulators to advance the manufacturing of new therapeutics
Noon – 1:30 p.m.     Lunch
1:30 – 3 p.m.  Bio Manufacturing Forum - Bio Manufacturing Showcase and Facilitated Networking

John Balchunas, NIIMBL
Gregory Theyel, Biomedical Manufacturing Network
Chris Yochim, NIIMBL 

Participants will learn how the National Institute for Innovation in Manufacturing Biologicals (NIIMBL) partners with industry, academia, non-profits, and government agencies; And collaborates on innovative manufacturing technologies that bring these life-saving and life-enhancing products to market faster and at reduced cost, while maintaining safety and efficacy. Industry and academic representatives will have an opportunity to network and engage, while sharing areas of common interest and priority areas for collaboration.  
3 – 3:30 p.m.              Break
3:30 – 5 p.m. Emerging Needs in Bio Manufacturing Education and Workforce Development

John Balchunas, NIIMBL
Jason Davis, Rensselaer Polytechnic Institute (RPI)
Guy Hamilton, Shoreline Community College
Jenny Ligon, National Center for Therapeutics Manufacturing
Snehal Patel, Juno Therapeutics

The community of education, training, and workforce development professionals are keenly-focused on "emerging” technologies such as gene therapy, cell-based therapies, gene editing, and regenerative medicine. Caught up in the race to commercialization, industry and academia are developing new processes, new job classifications, and disruptive technologies that could change the manufacturing paradigm altogether. This session will explore how broad communication, collaboration, and partnership is critical to ensuring tomorrow’s workforce is ready to drive this next wave of technology innovation and adoption.
5 – 7:30 p.m.              Networking Reception
Socializing face-to-face with colleagues and industry pros has never been easier. Bring business cards!

Titanium Sponsors


Platinum Sponsors

Elanco Animal Health
Longford Capital Management
Nixon Peabody LLP

Gold Sponsors

Leydig, Voit & Mayer Ltd
Klarquist Sparkman

Silver Sponsors

Marshall Gerstein
Michael Best & Friedrich
Life Science Washington
WSU Office of Commercialization
Christensen O'Connor Johnson Kindness
Schwabe, Williamson & Wyatt PC
Knowledge Sharing Systems